Author: Asebey Law

Liaoning Cheng Da USA Inc. of San Gabriel, California is Recalling Hot Pot Sauce Because it May Contain Undeclared Peanut, Soy, Sesame, and Wheat

On March 11, 2025, Liaoning Cheng Da USA Inc. of San Gabriel, California is recalling Hot Pot Sauce Because it may contain undeclared peanut, soy, sesame, and wheat. People who have an allergy or severe sensitivity to peanut, soy, sesame, and wheat run the risk of serious or life-threatening allergi Read More (external link)...

Continue reading

Immune Globulin Intravenous (IGIV) and Immune Globulin Subcutaneous (IGSC): Voluntary Lot Withdrawals – Due to Increased Reports of Allergic/Hypersensitivity Reactions

As a precautionary measure, the following lots of Immune Globulin Intravenous (IGIV) and Immune Globulin Subcutaneous (IGSC) have been voluntarily withdrawn by the manufacturers due to a higher rate of allergic/hypersensitivity type reactions, some of which were considered medically significant. Read More (external link)...

Continue reading

New York Wholesale Group Recalls Zaarah Herbals Rasayan Churan, Zaarah Herbals Gurmar Powder, Zaarah Herbals Vasaka Powder and Zaarah Herbals Bhringraj Powder Because of Possible Health Risk

New York Wholesale Group of Hicksville, NY is recalling Zaarah Herbals Rasayan Churan, Zaarah Herbals Gurmar Powder, Zaarah Herbals Vasaka Powder, and Zaarah Herbals Bhringraj Powder to the consumer/user level because it has the potential to be contaminated with elevated levels of lead and arsenic. Read More (external link)...

Continue reading

Smiths Medical Issues Urgent Medical Device Correction Informing Customers of a Potential Issue with Certain Sizes of Intubation ORAL/NASAL Endotracheal Tubes Being Smaller Than Expected

Smiths Medical has issued an Urgent Medical Device Correction to notify affected global customers of a potential issue with the 2.0, 2.5, 3.0 and 3.5 mm sizes of Intubation ORAL/NASAL Endotracheal Tube products being smaller than expected. Read More (external link)...

Continue reading

FDA Resolves Semaglutide Shortage: What It Means for Ozempic®, Wegovy®, and Compounded Versions

FDA Declares End to Semaglutide Shortage On February 21, 2025, the FDA issued a declaratory order announcing that the shortage of semaglutide injection products — namely Ozempic® and Wegovy® — has been resolved. Semaglutide, a GLP-1 receptor agonist used to manage type 2 diabetes, and obesity, had been in short supply since 2022 due to unprecedented patient demand. FDA confirmed that Novo Nordisk’s current production capacity now meets or exceeds both current and projected national demand, although some localized supply disruptions may still occur as products move through the supply chain. Compounding Pharmacy Exceptions: FDA Regulations, Drug Shortages, and Clinical Necessity Compounding is...

Continue reading

Nova-Tech, Inc. Issues Voluntary Nationwide Recall of Lactated Ringers 5 L Injectable Solution for Veterinary Use Due to Potential Presence of Fiber-like Particles

Grand Island, Nebraska, Nova-Tech, Inc. is voluntarily recalling one (1) lot of Lactated Ringers Injection for Animal Use Only to the end user level. The Lactated Ringers Injection has been found to potentially contain fiber- like visible particles. Read More (external link)...

Continue reading

One Source Nutrition, Inc. Issues Voluntary Nationwide Recall of Vitality Capsules Due to Presence of Undeclared Sildenafil and Tadalafil

One Source Nutrition is voluntarily recalling all lots of Vitality capsules to the Consumer level. FDA analysis has found the product to be tainted with sildenafil and tadalafil, which are ingredients in FDA approved products for treatment of male erectile dysfunction in the family of drugs known as Read More (external link)...

Continue reading